tiprankstipranks
Trending News
More News >
Genor Biopharma Holdings Limited (HK:6998)
:6998
Hong Kong Market

Genor Biopharma Holdings Limited (6998) Income Statement

Compare
3 Followers

Genor Biopharma Holdings Limited Income Statement

Last quarter (Q2 2025), Genor Biopharma Holdings Limited's total revenue was ¥32.24M, an increase of Infinity% from the same quarter last year. In Q2, Genor Biopharma Holdings Limited's net income was ¥-54.27M. See Genor Biopharma Holdings Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 206.23M¥ 0.00¥ 15.93M¥ 0.00¥ 10.33M
Gross Profit
¥ 204.89M¥ 0.00¥ 14.95M¥ 0.00¥ 7.74M
Operating Expenses
¥ 277.44M¥ 711.20M¥ 801.15M¥ 859.11M¥ 932.16M
Depreciation and Amortization
¥ 65.28M¥ 65.28M¥ 53.68M¥ 44.01M¥ 50.48M
EBITDA
¥ -5.15M¥ -551.01M¥ -675.89M¥ -840.19M¥ -2.98B
Operating Income
¥ -72.55M¥ -711.20M¥ -786.21M¥ -859.11M¥ -2.90B
Other Income/Expenses
¥ 37.42M¥ 33.70M¥ 50.30M¥ -7.20M¥ -133.29M
Pretax Income
¥ -35.13M¥ -677.50M¥ -732.42M¥ -866.31M¥ -3.04B
Net Income
¥ -51.28M¥ -674.36M¥ -730.40M¥ -865.37M¥ -3.03B
Per Share Metrics
Basic EPS
¥ -0.10¥ -1.33¥ -1.45¥ -1.75¥ -6.25
Diluted EPS
¥ -0.10¥ -1.33¥ -1.45¥ -1.74¥ -6.23
Weighted Average Shares Outstanding
513.55M 506.25M 504.30M 495.18M 484.99M
Weighted Average Shares Outstanding (Diluted)
513.55M 506.25M 504.81M 496.20M 486.24M
Currency in CNY

Genor Biopharma Holdings Limited Earnings and Revenue History